Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bicycle Therapeutics (BCYC) Return on Sales (2018 - 2025)

Bicycle Therapeutics (BCYC) has disclosed Return on Sales for 8 consecutive years, with 5.03% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Sales rose 1397.0% year-over-year to 5.03%, compared with a TTM value of 23.7% through Sep 2025, up 422.0%, and an annual FY2024 reading of 13.27%, up 4807.0% over the prior year.
  • Return on Sales was 5.03% for Q3 2025 at Bicycle Therapeutics, up from 27.05% in the prior quarter.
  • Across five years, Return on Sales topped out at 3.23% in Q4 2023 and bottomed at 27.05% in Q2 2025.
  • Average Return on Sales over 5 years is 8.27%, with a median of 6.09% recorded in 2025.
  • The sharpest move saw Return on Sales soared 2029bps in 2022, then tumbled -2280bps in 2025.
  • Year by year, Return on Sales stood at 23.86% in 2021, then surged by 85bps to 3.57% in 2022, then surged by 191bps to 3.23% in 2023, then tumbled by -283bps to 5.91% in 2024, then grew by 15bps to 5.03% in 2025.
  • Business Quant data shows Return on Sales for BCYC at 5.03% in Q3 2025, 27.05% in Q2 2025, and 6.09% in Q1 2025.